Test Price
2,800 AED✅ Home Collection Available
CIB2 Gene (Autosomal Recessive Type 48) Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
Accuracy Guarantee
99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM).
Clinical Guidance
Post‑test telephonic genetic counseling to interpret results and plan next steps under the supervision of our Consultant Medical Genetics.
Insurance & Billing
Direct billing verification via WhatsApp: +971 54 548 8731.
Test Overview & Methodology
This Next‑Generation Sequencing (NGS) test analyses the entire coding region of the CIB2 gene to identify pathogenic variants responsible for autosomal recessive deafness type 48 (DFNB48). In the UAE, it provides conclusive molecular diagnosis for congenital sensorineural hearing loss, guiding audiological rehabilitation and family planning under DHA‑endorsed protocols.
| Feature | Our CIB2 NGS Test | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Methodology | Full‑gene Next‑Generation Sequencing | Sanger sequencing of selected exons |
| Detection Rate | >99% of known pathogenic variants | Misses deep intronic or large deletions |
| Turnaround Time | 3‑4 Weeks | 4‑6 Weeks |
| Clinical Use | Early intervention, carrier screening, genetic counseling | Suspected familial variant only |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I know that receiving a diagnosis of hereditary hearing loss can be life‑changing. This CIB2 NGS test provides families with a definitive molecular answer, enabling timely cochlear implantation or early intervention. Always remember, genetic results must be integrated with audiological and clinical assessments. We are here to guide you through this journey.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Pre-Test Advisory
A detailed clinical history of the patient’s hearing loss (onset, severity, family history) must be provided. A genetic counselling session will draw a pedigree chart to assess inheritance patterns. No medication changes or special preparation is needed.
Sample Accepted: Whole Blood (EDTA tube), Extracted DNA, or one drop of blood on an FTA card.
Exclusion Criteria & Safety Red Flags
- Exclusion: Individuals with active ear infection requiring urgent treatment should defer collection until cleared by an ENT specialist.
- Minors: Informed consent from legal guardian is mandatory, in compliance with Federal Decree‑Law No. 4 of 2016 on Medical Liability. Prenatal testing requires additional genetic counselling.
- Emergency Alert: If you experience sudden, severe hearing loss, vertigo, or tinnitus, seek immediate ENT evaluation before booking this test.
Always consult your physician before discontinuing any prescribed medications. This test does not replace ongoing treatment.
Patient FAQ & Clinical Guidance
1. What is the purpose of the CIB2 Gene Genetic Test?
The CIB2 Genetic Test detects mutations in the CIB2 gene responsible for autosomal recessive deafness type 48, providing a definitive molecular diagnosis for hereditary hearing loss.
2. How is the sample collected for this test?
A simple blood draw or a finger‑prick onto an FTA card is performed by our DHA‑licensed phlebotomist during your home collection appointment.
3. How long until I receive results and what happens next?
Results are typically ready in 3–4 weeks, and our Consultant Medical Genetics provides a telephonic consultation to explain the findings and recommend next steps.
UAE Regulatory & Data Privacy Adherence
Compliance & Confidentiality
This test is performed in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data are handled with strict confidentiality and in accordance with DHA guidelines. The laboratory holds ISO 9001:2015 accreditation (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | CIB2 Gene (Autosomal Recessive Type 48) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA tube), Extracted DNA, or FTA Card |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full Gene Analysis |
| ICD-10-CM Code | H90.5 (Sensorineural hearing loss, unspecified) |
| LOINC Code | 52900-0 (CIB2 gene mutation analysis) |
| DHA Facility License & Laboratory Address | DHA License No: 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians